On the two-year anniversary of the COVID-19 pandemic, take a look back at the Gulf States Newsroom’s coverage of the infectious disease’s impact on the Gulf South region.
The Trump EPA announced this week that it will not lower the current limit on particulate air pollution, an action that disappointed but didn’t surprise public health scientists and clean-air advocates.
In the search for a drug treatment for COVID-19, prime interest has centered on Remdesivir, a compound produced by Gilead Sciences that has its roots in a National Institutes of Health-funded center based at UAB.